Livzon Pharmaceutical elects employee director, adjusts board committees

Livzon Pharmaceutical Group completed the election of Ms. Wang Zhiyao as an independent non-executive director at its first extraordinary general meeting in 2025 on December 10, 2025. This ensures independent directors constitute at least one-third of the board, complying with regulatory requirements.

On the same day, the company's employee representative meeting elected Ms. Ran Yongmei as the employee representative director for the eleventh session of the board. Ms. Ran, 42, holds a bachelor of pharmacy degree and previously held positions at various pharmaceutical companies before joining Livzon in January 2022 as assistant president and deputy general manager of Zhuhai Livzon Mab Biologics Co., Ltd. Her appointment ensures that the number of senior management and employee representative directors does not exceed half of the total board members.

Additionally, the board's special committees have been restructured. Key changes include Ms. Cui Lijie leading the remuneration and assessment committee, while Mr. Bai Hua chairs the audit committee. Mr. Zhu Baoguo will lead both the environmental, social, and governance committee and the strategy committee. These adjustments aim to ensure the efficient operation of the board’s specialized functions.